This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
B-cell lymphoma protein
From Proteopedia
(Difference between revisions)
| Line 47: | Line 47: | ||
**[[3inq]] - hBcl-xL (mutant) + inhibitor<br /> | **[[3inq]] - hBcl-xL (mutant) + inhibitor<br /> | ||
**[[1ysg]] - hBcl-xL + inhibitor<br /> | **[[1ysg]] - hBcl-xL + inhibitor<br /> | ||
| + | **[[5fmk]] - hBcl-xL + Bcl-2 BH3 domain<br /> | ||
**[[2w3l]] – hBcl-xL + quinoline derivative<br /> | **[[2w3l]] – hBcl-xL + quinoline derivative<br /> | ||
**[[2o1y]], [[2o2m]], [[2o2n]], [[1ysi]], [[1ysn]] - hBcl-xL + sulfonamide derivative – NMR<br /> | **[[2o1y]], [[2o2m]], [[2o2n]], [[1ysi]], [[1ysn]] - hBcl-xL + sulfonamide derivative – NMR<br /> | ||
| Line 64: | Line 65: | ||
**[[1gjh]], [[1g5m]] – hBcl-2<br /> | **[[1gjh]], [[1g5m]] – hBcl-2<br /> | ||
| - | **[[4aq3]], [[4man]] – hBcl-2 + inhibitor<br /> | + | **[[4aq3]], [[4man]], [[5jsn]] – hBcl-2 + inhibitor<br /> |
**[[4lvt]], [[4lxd]] – hBcl-2 (mutant) + inhibitor<br /> | **[[4lvt]], [[4lxd]] – hBcl-2 (mutant) + inhibitor<br /> | ||
| + | **[[5fcg]] – hBcl-2 (mutant) + HBX peptide<br /> | ||
**[[2xa0]] – hBcl-2 residues 1-207 + apoptosis regulator BAX BH3 domain<br /> | **[[2xa0]] – hBcl-2 residues 1-207 + apoptosis regulator BAX BH3 domain<br /> | ||
**[[2o21]], [[2o22]], [[2o2f]], [[1ysw]] - hBcl-2 + sulfonamide derivative - NMR<br /> | **[[2o21]], [[2o22]], [[2o2f]], [[1ysw]] - hBcl-2 + sulfonamide derivative - NMR<br /> | ||
| Line 95: | Line 97: | ||
**[[3d7v]], [[2pqk]] - hMcl-1 fragment + hBcl-2-L-11 BIM BH3<br /> | **[[3d7v]], [[2pqk]] - hMcl-1 fragment + hBcl-2-L-11 BIM BH3<br /> | ||
**[[2kbw]] - hMcl-1 fragment + BID BH3 peptide – NMR<br /> | **[[2kbw]] - hMcl-1 fragment + BID BH3 peptide – NMR<br /> | ||
| - | **[[3wix]], [[3wiy]], [[4oq5]], 4oq6]] - hMcl-1 fragment + inhibitor<br /> | + | **[[4wms]] - hMcl-1/MBP (mutant) <br /> |
| + | **[[5lof]] - hMcl-1/MBP + inhibitor<br /> | ||
| + | **[[4wmx]], [[4wmw]], [[4wmv]] - hMcl-1/MBP + ligand<br /> | ||
| + | **[[4wmu]], [[4wmt]] - hMcl-1/MBP (mutant) + ligand<br /> | ||
| + | **[[4wgi]] - hMcl-1/MBP (mutant) + macrolactam<br /> | ||
| + | **[[3wix]], [[3wiy]], [[4oq5]], [[4oq6]] - hMcl-1 fragment + inhibitor<br /> | ||
**[[4bpj]] - hMcl-1 fragment + BH3 peptide <br /> | **[[4bpj]] - hMcl-1 fragment + BH3 peptide <br /> | ||
Revision as of 10:38, 14 March 2017
| |||||||||||
3D structures of Bcl-2
Updated on 14-March-2017
References
Proteopedia Page Contributors and Editors (what is this?)
Michal Harel, Colin Ridenour, David Canner, Alexander Berchansky, Jaime Prilusky
Categories: Topic Page | Bcl 2 | Bax | Bok | Bad | Bak | Bcl-xl | Bcl xl | Bcl-w | Bcl w | Apoptosis | Mmp | Mitochondrial membrane permeabilization | B cell lymphoma 2 | Signal transduction

